Follicular Lymphoma Video Perspectives

In this video series, Noah Merin, MD, PhD, from the Blood and Marrow Transplantation Program and assistant professor of medicine at Cedars-Sinai Medical Center, discussed:

• The “watch-and-wait” approach for the treatment of follicular lymphoma in newly diagnosed patients;
• Bispecific antibodies, their toxicities and their potential in follicular lymphoma;
• First-line treatments and options for relapsed or refractory disease;
• The “complicated decision-making process” when talking with patients about CAR-T and autologous and allogenic transplantation, as well as how using minimal residual disease testing may help with this process in the future; and
• Challenges in follicular lymphoma, such as “making the more intense therapies safer so that more people can get them.”